Medacist Solutions Group is the lead innovator in drug diversion analytics as evidenced by being granted the only U.S. patent for drug diversion. Our core initiative is to deliver actionable information focused on the medication use process to drive better patient safety outcomes for the clients we serve. As such, we are proud to say that thousands of hospitals across the U.S. have relied on our analytics suites to ensure regulatory compliance, reduce liability, and ensure patient safety.
In Drug Diversion Analytics
Pharmacy Analytics Experience
Serving our clients for the past 21 Years!
Only U.S. patent
In Drug Diversion
Named Top 10 Analytics Solution Provider in 2019
Are You Ready for the Future of Drug Diversion Analytics?
The Genesis Analytics platform provides:
A packaged solution for all data sources
- IaaS (interoperability) as a service
- Vendor Agnostic Compatibility
Real-time insights that are action ready
- Minimized time to action via autonomous tuning
- 24/7 real-time ingestion & streaming analytics
Data lake like no other
- 10.1 Petabytes – ADS & EMR Transaction Data
- >197 Million Patients Protected
- 2,000+ Hospitals
- 2,830,523 Clinical Staff Monitored
The Genesis Analytics platform is built on a new engine quantified through a knowledge base comprised of over 20 years of industry exclusive ADS and EMR data from thousands of facilities across the country. This engine powers our machine learning algorithms developed to identify diversion pattern recognition, learned and confirmed by actual diversion events.
Does Your Hospital struggle with Drug Diversion?
With RxAuditor, hospitals across the country benefit from strategic use of information which helps:
- Reduce drug diversion
- Reduce workflow inefficiencies
- Assure an accurate and safe medication practice
- Improve accountability of healthcare providers
- Regulatory compliance and reduction in healthcare liability
Medacist provides the RxAuditor analytics suite as a SaaS delivery model to the acute and long-term health care industry assisting its clients in a variety of ways through the following services: RxAuditor OnDemand, RxAuditor 360 and RxAuditor CPA.
How are You Tackling the National Opioid Epidemic?
ScripTrac synergistically melds electronic medical record data, big data analytics, and artificial intelligence machine learning to form a web based application for both healthcare administration and clinicians. ScripTrac’s main components are:
- Prescription monitoring between practitioner and patient
- Provider prescribing practice evaluation based on scores on specific prescribing metrics
- Provider prescribing practice benchmarking by peer group, patient care area, facility, health system, and nationally
- Predictive addiction targeting using artificial intelligence to identify potential addiction risks based on past patterns and outcomes
When presented with the task of finding a solution to our nation’s “opioid epidemic”, Medacist answered with ScripTrac Analytics.
people died from drug overdoses in the U.S. in 2016
used prescription painkillers in the past year
hospitals in the United States with potential for drug diversion
of patient care professionals are abusing or dependent on prescription drugs in a given year
I love the visual aspects of RxAuditor Investigate. I find the assurance metrics section to be exceptionally helpful by comparing the user to their peers. I would like to give RxAuditor Investigate credit for the “aha moment”. Our diversion team (which is multidisciplinary) was very impressed that the two most recent people we had been investigating for possible diversion were confirmed by RxAuditor Investigate. Well done!Joni Street RPh, BCPS Inpatient Pharmacy Supervisor and Diversion Officer Creighton University Med Center - Bergan Mercy
As a division leader, RxAuditor Investigate has allowed me the ability to assess the status of all 14 facilities from one diversion risk dashboard, providing point and click ability to drill down on potential areas of concern. RxAuditor Investigate is an improved communication tool for the multidisciplinary teams and allows those teams to come to a quicker resolution when outliers are identified.Mike Tiesi RP, FACHE Division VP Pharmacy Services CHI Fargo & CHI Health
Since we began using RxAuditor Investigate, the investigation time and throughput have not only improved in resources used but also in communication between disciplines. Through the RxAuditor Investigate platform, we have decreased the number of persons requiring investigation by 50-75%. Tucson Medical Center’s Diversion Investigation team has been very happy with our involvement in the RxAuditor Investigate platform and it has truly made our hospital a safer place.Zachary Hodges, PharmD, BCCCP Medication Safety Officer Tucson Medical Center
RxAuditor gives me the ability to analyze data in a quick and comprehensive manner. It goes beyond ‘transactions per month’ to assess ‘transactions per shift’, the percent of ADM transactions involving controlled substances, waste pairings, and much more. I greatly value having access to these data as a part of our diversion prevention and detection program.Brian O’Neal, PharmD, MS, FASHP Senior Director of Pharmacy and Biomedical Engineering Children’s Mercy Kansas City
We have had several diversion situations identified that we would not have known about or caught without the use of the RxAuditor report. Just recently we identified a nurse that had been diverting from the hospital for 4 years. She started showing up on our RxAuditor report for Dilaudid (hydromorphone) for the last year. There were several “educational” conversations that took place and nursing leadership medication administration observations. The trouble with our situation was she was a very high performing nurse that received compliments from both staff and patients. She was “the last person you would suspect to be diverting.” The report finally told the story. This finally hit home to the nursing leadership and she was brought in for a drug screen. She openly shared what she had been doing and really seemed to be relieved that this was ending.Stacy Boatright, RPh Director of Pharmacy Women’s & Children’s Hospital